---
layout: post
title: "INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit"
date: 2026-02-21T23:05:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/ino-investors-have-opportunity-to-lead-inovio-pharmaceuticals-inc-securities-fraud-lawsuit-302693778.html
significance: 8.00
---

<p>NEW YORK, Feb. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/ino-investors-have-opportunity-to-lead-inovio-pharmaceuticals-inc-securities-fraud-lawsuit-302693778.html)

**Published:** 2026-02-21 23:05:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/ino-investors-have-opportunity-to-lead-inovio-pharmaceuticals-inc-securities-fraud-lawsuit-302693778.html)
